43 related articles for article (PubMed ID: 18584942)
1. Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma.
Kim YS; Kim K; Kwon GY; Lee SJ; Park SH
BMC Urol; 2018 Jul; 18(1):68. PubMed ID: 30064409
[TBL] [Abstract][Full Text] [Related]
2. Editorial Comment to Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
Kondo T
Int J Urol; 2024 Feb; 31(2):133. PubMed ID: 37997623
[No Abstract] [Full Text] [Related]
3. Comprehensive integrative profiling of upper tract urothelial carcinomas.
Su X; Lu X; Bazai SK; Compérat E; Mouawad R; Yao H; Rouprêt M; Spano JP; Khayat D; Davidson I; Tannir NN; Yan F; Malouf GG
Genome Biol; 2021 Jan; 22(1):7. PubMed ID: 33397444
[TBL] [Abstract][Full Text] [Related]
4. Editorial Comment on Epigenetic alterations in urothelial bladder cancer associated with disease outcomes.
Arai S
Int J Urol; 2024 Mar; 31(3):229-230. PubMed ID: 38071741
[No Abstract] [Full Text] [Related]
5. Regarding the role of HER2 overexpression on the survival in muscle-invasive bladder cancer.
Yang W; Liu J
Int J Surg; 2024 Apr; 110(4):2466. PubMed ID: 38241347
[No Abstract] [Full Text] [Related]
6. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma.
Mossanen M; Chang SL; Kimm S; Sonpavde GP; Kibel AS
Urol Clin North Am; 2018 May; 45(2):143-154. PubMed ID: 29650131
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Burger M
Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
[No Abstract] [Full Text] [Related]
8. FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
van Oers JM; Zwarthoff EC; Rehman I; Azzouzi AR; Cussenot O; Meuth M; Hamdy FC; Catto JW
Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
Montironi R; Lopez-Beltran A; Cheng L
Eur Urol; 2008 Oct; 54(4):843-4. PubMed ID: 18166261
[No Abstract] [Full Text] [Related]
10. Editorial comment.
Weiss RE
Urology; 2010 Feb; 75(2):333. PubMed ID: 20152483
[No Abstract] [Full Text] [Related]
11. Editorial comment.
Shayegan B
Urology; 2010 Feb; 75(2):332-3. PubMed ID: 20152482
[No Abstract] [Full Text] [Related]
12. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Malats N; Real FX
Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
[No Abstract] [Full Text] [Related]
13. [Transitional cell carcinoma of the upper urinary tract new concepts in management].
Rouprêt M; Cussenot O
Presse Med; 2005 Apr; 34(8):601-7. PubMed ID: 15962502
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
